New York Life Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
New York Life Investment Management's BMY Position: Q2 2026 in Review
New York Life Investment Management increased its Bristol-Myers Squibb (BMY) stake by 0.19% in Q2 2026, buying an estimated $32.4K and bringing the position to 303,600 shares worth $17.5M. The position accounts for 0.12% of the portfolio, ranked #143.
New York Life Investment Management first reported a position in BMY in Q2 2022 and has held it in 17 quarters since. The position peaked at $26.2M in Q2 2022. 1,717 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- New York Life Investment Management held 303,600 shares of Bristol-Myers Squibb worth $17.5M as of Q2 2026.
- New York Life Investment Management bought 565 Bristol-Myers Squibb shares in Q2 2026, an estimated $32.4K.
- Bristol-Myers Squibb made up 0.12% of New York Life Investment Management's portfolio in Q2 2026, its #143 holding.
- New York Life Investment Management first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 17 quarters since.
- New York Life Investment Management's Bristol-Myers Squibb position peaked at $26.2M in Q2 2022.
- 1,717 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.